p53 as a mutagen test in breast cancer

Environmental and Molecular Mutagenesis

Volumn 39, Issue 2-3, 2002, Pages 216-227

  Hill, Kathleen A ^a   Sommer, Steve S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Endogenous processes; Environmental mutagens; Genetic predisposition; Mutagen test; Mutation load; Mutation pattern; Mutation scanning; P53 gene; Spontaneous mutations

Indexed keywords

MUTAGENIC AGENT; PROTEIN P53;

BREAST CANCER; BREAST EPITHELIUM; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CONFERENCE PAPER; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; HUMAN; IMMUNOHISTOCHEMISTRY; MUTAGEN TESTING; PREDICTION; TREATMENT FAILURE;

BREAST NEOPLASMS; COHORT STUDIES; DNA, NEOPLASM; FEMALE; GENES, P53; HUMANS; MUTAGENICITY TESTS; MUTATION;

EID: 0036202781     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10065     Document Type: Conference Paper

References (99)

1. 1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes
2. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
3. Prognostic value of the immunohistochemical expression of p53 in breast carcinomas: A review of the literature involving over 9,000 patients
4. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
5. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
6. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies
7. Adipose tissue, a neglected factor in aetiology of breast cancer?
8. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer
9. Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer
10. Rapid and efficient screening for p53 gene mutations by dideoxyfingerprinting (ddF)
11. Molecular epidemiology of breast cancers in northern and southern Japan: The frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populations
12. A prospective trial of midwest breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome
13. Cancer statistics, 1994
14. Why does the human factor IX gene have a G + C content of 40%?
15. The pattern of spontaneous germline mutation: Relative rates of mutation at or near CpG dinucleotides in the factor IX gene
16. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
17. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
18. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue transgenic mice
19. Spontaneous mutation frequencies and spectra in p53 (+/+) and p53 (-/-) mice: A test of the "guardian of the genome" hypothesis in the Big Blue transgenic mouse mutation detection system
20. Neighboring base effects on substitution rates in pseudogenes
21. Nutritional risk factors for breast cancer
22. Prognostic significance of p53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay
23. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots
24. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
25. Diet and breast cancer: Review of the epidemiologic literature
26. Trends in breast cancer incidence, survival, and mortality
27. Trends in cancer incidence and mortality
28. Relation between p53 overexpression and established prognostic factors in breast cancer
29. Novel hotspot detector software reveals a non-CpG hotspot of germline mutation in the factor IX gene (F9) in Latin Americans
30. Environmental carcinogens that may be involved in human breast cancer etiology
31. The relative rates of ancient germline mutations during human evolution are similar to those of recent germline mutations
32. Workshop report: Identification of research needs breast cancer etiology
33. Patterns of nucleotide substitution in pseudogenes and functional genes
34. Germline mutations in the factor IX gene: A comparison of the pattern in Caucasians and non-Caucasians
35. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
36. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer
37. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
38. 53 Tumor suppressor gene: From the basic research laboratory to the clinic - An abridged historical perspective
39. Clinical implications of the p53 tumor-suppressor gene
40. Adsorption of a hydrophobic mutagen to cereal brans and cereal bran dietary fibres
41. p53 gene mutations inside and outside of exons 5-8: The patterns differ in breast and other cancers
42. Novel pattern of p53 mutation in breast cancers from Austrian women
43. High frequency of p53 mutations in primary breast cancers in Japanese women, a low-incidence population
44. Toward efficient analysis of mutations in single cells from ethanol-fixed, paraffin-emmbedded and immunohistochemically-stained tissues
45. Germline mutations in Peruvian patients with hemophilia B: Pattern of mutation in AmerIndians is similar to the putative endogenous germline pattern
46. Fatty acid composition of phospholipids and neutral lipids and lipid peroxidation in human breast cancer and lipoma tissue
47. Human cancer: Epidemiology and environmental causes
48. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
49. Cohort studies of fat intake and the risk of breast cancer - A pooled analysis
50. p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer
51. Trends in breast cancer incidence, survival, and mortality
52. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
53. The rates of G:C→T:A and G:C→C:G transversions at CpG dinucleotides in the human factor IX gene
54. Direct sequencing from touch preparations of human carcinomas: Analysis of p53 mutations in breast carcinomas
55. Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value
56. p53, guardian of the genome
57. Aberrations of p53 gene in human hepatocellular carcinoma from China
58. Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications
59. Factor IX mutations in South Africans and African Americans are compatible with primarily endogenous influences upon recent germline mutations
60. The human factor IX gene as germline mutagen test: Samples from mainland China have the putatively endogenous pattern of mutation
61. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
62. Effect of varying the type of fat in a semi-purified AIN-76A diet on cellular proliferation in the mammary gland and intestinal crypts in female Swiss Webster mice
63. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
64. DNA adduct formation and molecular analysis of in vivo lacl mutations in the mammary tissue of Big Blue rats treated with 7,12-dimethylbenz[a]anthracene
65. DNA damage in breast epithelial cells: Detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts
66. Morphological transformation of C3H/M2 mouse fibroblasts by extracts of human mammary lipid
67. DNA strand breaks and cell transformation induced by human mammary lipid extracts
68. Genotoxicity of human milk extracts and detection of DNA damage in exfoliated cells recovered from breast milk
69. Studying environmental influences and breast cancer risk: Suggestions for an integrated population-based approach
70. The contribution of exogenous and endogenous mutagens to in vivo mutations
71. Mutagenic activity in nipple aspirates of human breast fluid
72. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours
73. First report on UK database of haemophilia B mutations and pedigrees
74. p53 gene mutations in breast cancers in Midwestern U.S. women: Null as well as missense-type mutations are associated with poor prognosis
75. p53 deficiency does not affect the accumulation of point mutations in a transgene target
76. Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations
77. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
78. Mutagenic response of the endogenous hprt gene and lacl transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice
79. Mutagen test
80. Does cancer kill the individual and save the species?
81. A postulated mechanism for deletions with inversions
82. Human germline mutation in the factor IX gene
83. Structural aspects of the p53 protein in relation to gene evolution
84. Multifactorial analysis of p53 alteration in human cancer: A review
85. The pathology of breast cancer in Japanese women compared to other ethnic groups: A review
86. p53 mutations in lung cancers from non-smoking atomic-bomb survivors
87. Molecular epidemiology of factor IX germline mutations in Mexican Hispanics: Pattern of mutation and potential founder effects
88. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas
89. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacl loci in splenic lymphocytes of exposed lacl transgenic mice
90. Interrelationship between dietary lipids and calories and experimental mammary gland tumorigenesis
91. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors
92. Dietary fat and carcinogenesis
93. Breast fluid cholesterol and cholesterol beta-epoxide concentrations in women with benign breast disease
94. Breast cancer: Weighing the evidence for a promoting role of dietary fat
95. Model of mouse mammary gland hyperproliferation and hyperplasia induced by a Western-style diet
96. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
97. A comparison of the biological activities of wild-type and mutant p53
98. Migration patterns and breast cancer risk in Asian-American women